Next year's sales outlook
The outlook will show how much growth Lilly expects as its obesity and diabetes medicines reach more patients.
Eli Lilly & Co reports its Q4 FY2026 results on 3 February 2027, before the market opens. Analysts expect earnings per share of 11.19 USD and revenue of 24.58B USD.
In Q3 FY2026, reported on 29 October 2026, Eli Lilly & Co earned 7.48 USD a share against the 5.71 USD analysts expected (+31.0%), on revenue of 24.40B USD against 22.58B USD (+8.0%).
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth | Next-day move |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 10.93 | — | — | +27.89% | 23.62B | — | — | +19.31% | — | |
| Q4 FY2026 | 11.19 | — | — | +48.41% | 24.58B | — | — | +27.42% | — | |
| Q3 FY2026 | 5.71 | 7.48 | +31.00% | +6.55% | 22.58B | 24.40B | +8.03% | +38.61% | +6.5% | |
| Q2 FY2026 | 6.40 | 8.38 | +30.94% | +32.81% | 20.82B | 22.97B | +10.33% | +47.67% | +4.7% | |
| Q1 FY2026 | 6.97 | 8.55 | +22.67% | +155.99% | 17.82B | 19.80B | +11.11% | +55.55% | +9.8% | |
| Q4 FY2025 | 6.91 | 7.54 | +9.12% | +41.73% | 17.94B | 19.29B | +7.51% | +42.56% | +10.5% | |
| Q3 FY2025 | 5.69 | 7.02 | +23.37% | +494.92% | 16.05B | 17.60B | +9.64% | +53.87% | +3.8% | |
| Q2 FY2025 | 5.60 | 6.31 | +12.68% | +60.97% | 14.70B | 15.56B | +5.80% | +37.64% | -14.2% | |
| Q1 FY2025 | 3.26 | 3.34 | +2.45% | +29.46% | 12.67B | 12.73B | +0.48% | +45.17% | -11.5% | |
| Q4 FY2024 | 5.03 | 5.32 | +5.77% | +113.65% | — | 13.53B | — | +44.68% | +3.4% | |
| Q3 FY2024 | 1.47 | 1.18 | -19.73% | +1,080.00% | 12.10B | 11.44B | -5.44% | +20.43% | -6.3% | |
| Q2 FY2024 | 2.60 | 3.92 | +50.77% | +85.78% | 9.98B | 11.30B | +13.24% | +35.98% | +9.2% | |
| Q1 FY2024 | 2.46 | 2.58 | +4.88% | +59.26% | 8.94B | 8.77B | -1.88% | +25.98% | +6.0% | |
| Q4 FY2023 | 2.22 | 2.49 | +12.16% | +19.14% | 8.93B | 9.35B | +4.71% | +28.10% | -0.1% | |
| Q3 FY2023 | -0.08 | 0.10 | +225.00% | -94.95% | 8.95B | 9.50B | +6.08% | +36.84% | +4.6% | |
| Q2 FY2023 | 1.98 | 2.11 | +6.57% | +68.80% | 7.58B | 8.31B | +9.62% | +28.11% | +14.8% | |
| Q1 FY2023 | 1.73 | 1.62 | -6.36% | -38.17% | 7.55B | 6.96B | -7.83% | -10.88% | +3.8% | |
| Q4 FY2022 | 1.78 | 2.09 | +17.42% | -16.06% | 7.33B | 7.30B | -0.42% | -8.73% | -3.5% | |
| Q3 FY2022 | 1.92 | 1.98 | +3.13% | +2.06% | 6.89B | 6.94B | +0.78% | +2.49% | -2.6% | |
| Q2 FY2022 | 1.69 | 1.25 | -26.04% | -33.16% | 6.85B | 6.49B | -5.27% | -3.74% | -2.5% | |
| Q1 FY2022 | 2.32 | 2.62 | +12.93% | +40.11% | 7.29B | 7.81B | +7.18% | +14.76% | +4.4% | |
| Q4 FY2021 | 2.51 | 2.49 | -0.80% | -9.45% | 7.69B | 8.00B | +4.06% | +7.53% | -2.5% | |
| Q3 FY2021 | 1.98 | 1.94 | -2.02% | +25.97% | 6.57B | 6.77B | +3.08% | +17.98% | +1.4% | |
| Q2 FY2021 | 1.89 | 1.87 | -1.06% | -1.06% | 6.74B | 6.74B | 0.00% | +22.56% | +3.7% | |
| Q1 FY2021 | 2.12 | 1.87 | -11.79% | +6.86% | 7.64B | 6.81B | -10.88% | +16.14% | -2.8% | |
| Q4 FY2020 | 2.35 | 2.75 | +17.02% | +58.96% | 6.17B | 7.44B | +20.51% | +21.69% | -1.3% | |
| Q3 FY2020 | 1.71 | 1.54 | -9.94% | +4.05% | 6.37B | 5.74B | -9.93% | +4.82% | -7.0% | |
| Q2 FY2020 | 1.56 | 1.89 | +21.15% | +26.00% | 4.54B | 5.50B | +21.15% | -2.44% | -5.5% | |
| Q1 FY2020 | 1.48 | 1.75 | +18.24% | +31.58% | 4.96B | 5.86B | +18.24% | +15.07% | +2.2% | |
| Q4 FY2019 | 1.52 | 1.73 | +13.82% | +30.08% | 5.37B | 6.11B | +13.82% | -5.04% | +1.9% | |
| Q3 FY2019 | 1.41 | 1.48 | +4.96% | +6.47% | 5.22B | 5.48B | +4.96% | +3.20% | -2.3% | |
| Q2 FY2019 | 1.45 | 1.50 | +3.45% | 0.00% | 5.45B | 5.64B | +3.45% | +0.93% | -0.0% | |
| Q1 FY2019 | 1.32 | 1.33 | +0.76% | -0.75% | 5.02B | 5.09B | +1.53% | +2.59% | -2.1% | |
| Q4 FY2018 | 1.34 | 1.33 | -0.75% | +16.67% | 5.68B | 6.44B | +13.36% | +4.51% | -1.0% | |
| Q3 FY2018 | 1.35 | 1.39 | +2.96% | +32.38% | 5.15B | 5.31B | +2.96% | -6.21% | -4.3% | |
| Q2 FY2018 | 1.31 | 1.50 | +14.50% | +35.14% | 4.84B | 5.59B | +15.38% | -4.11% | +5.0% | |
| Q1 FY2018 | 1.13 | 1.34 | +18.58% | +36.73% | 4.19B | 4.96B | +18.58% | -5.06% | -0.1% | |
| Q4 FY2017 | 1.08 | 1.14 | +5.56% | +20.00% | 5.78B | 6.16B | +6.54% | +6.95% | -5.4% | |
| Q3 FY2017 | 1.03 | 1.05 | +1.94% | +19.32% | 5.55B | 5.66B | +1.94% | +8.98% | -2.3% | |
| Q2 FY2017 | 1.05 | 1.11 | +5.71% | +29.07% | 5.51B | 5.82B | +5.71% | +7.76% | -3.1% | |
| Q1 FY2017 | 0.96 | 0.98 | +2.08% | +18.07% | 5.12B | 5.23B | +2.08% | +7.47% | -2.7% | |
| Q4 FY2016 | 0.99 | 0.95 | -4.04% | +21.79% | 5.94B | 5.76B | -3.06% | +7.16% | +3.2% | |
| Q3 FY2016 | 0.96 | 0.88 | -8.33% | -1.12% | 5.66B | 5.19B | -8.33% | +4.68% | +0.4% | |
| Q2 FY2016 | 0.86 | 0.86 | 0.00% | -4.44% | 5.40B | 5.40B | 0.00% | +8.56% | +0.1% | |
| Q1 FY2016 | 0.85 | 0.83 | -2.35% | -4.60% | 4.98B | 4.87B | -2.35% | +4.75% | -2.1% | |
| Q4 FY2015 | 0.77 | 0.78 | +1.30% | +4.00% | 5.38B | 5.38B | 0.00% | +4.97% | -6.1% | |
| Q3 FY2015 | 0.76 | 0.89 | +17.11% | +34.85% | 4.24B | 4.96B | +17.11% | +1.72% | -0.0% | |
| Q2 FY2015 | 0.74 | 0.90 | +21.62% | +32.35% | 4.09B | 4.98B | +21.62% | +0.87% | +0.4% | |
| Q1 FY2015 | 0.76 | 0.87 | +14.47% | +24.29% | 4.11B | 4.64B | +12.99% | -0.82% | +0.1% | |
| Q4 FY2014 | 0.74 | 0.75 | +1.35% | +1.35% | 5.05B | 5.12B | +1.35% | -11.84% | -0.2% | |
| Q3 FY2014 | 0.66 | 0.66 | 0.00% | -40.54% | 4.95B | 4.88B | -1.49% | -15.54% | -0.5% | |
| Q2 FY2014 | 0.65 | 0.68 | +4.62% | -41.38% | 4.72B | 4.94B | +4.62% | -16.76% | +0.2% | |
| Q1 FY2014 | 0.70 | 0.70 | 0.00% | -38.60% | 4.68B | 4.68B | 0.00% | -16.40% | -1.5% | |
| Q4 FY2013 | 0.74 | 0.74 | 0.00% | -12.94% | 5.81B | 5.81B | 0.00% | -2.49% | -1.2% | |
| Q3 FY2013 | 1.04 | 1.11 | +6.73% | +40.51% | 5.41B | 5.77B | +6.73% | +6.05% | +0.3% | |
| Q2 FY2013 | 1.00 | 1.16 | +16.00% | +39.76% | 5.11B | 5.93B | +16.00% | +5.87% | +3.1% | |
| Q1 FY2013 | 1.05 | 1.14 | +8.57% | +23.91% | 5.16B | 5.60B | +8.57% | 0.00% | -3.9% | |
| Q4 FY2012 | 0.78 | 0.85 | +8.97% | -2.30% | 5.47B | 5.96B | +8.97% | -1.48% | +3.2% | |
| Q3 FY2012 | 0.83 | 0.79 | -4.82% | -30.09% | 5.72B | 5.44B | -4.82% | -11.46% | -2.7% | |
| Q2 FY2012 | 0.77 | 0.83 | +7.79% | -29.66% | 5.20B | 5.60B | +7.79% | -10.43% | +2.7% | |
| Q1 FY2012 | 0.78 | 0.92 | +17.95% | -25.81% | 4.75B | 5.60B | +17.95% | -4.06% | +2.1% | |
| Q4 FY2011 | 0.81 | 0.87 | +7.41% | -21.62% | 5.63B | 6.05B | +7.41% | -2.27% | +1.2% | |
| Q3 FY2011 | 1.13 | 1.13 | 0.00% | -6.61% | 6.15B | 6.15B | 0.00% | +8.72% | -0.2% | |
| Q2 FY2011 | 1.18 | 1.18 | 0.00% | -4.84% | 6.25B | 6.25B | 0.00% | +8.77% | +3.0% | |
| Q1 FY2011 | 1.17 | 1.24 | +5.98% | +5.08% | 5.51B | 5.84B | +5.98% | +6.45% | -1.1% | |
| Q4 FY2010 | 1.10 | 1.11 | +0.91% | +21.98% | 6.13B | 6.19B | +0.91% | +4.26% | +1.5% | |
| Q3 FY2010 | 1.15 | 1.21 | +5.22% | +0.83% | 5.37B | 5.65B | +5.22% | +1.67% | -1.4% | |
| Q2 FY2010 | 1.10 | 1.24 | +12.73% | +10.71% | 5.10B | 5.75B | +12.73% | +8.61% | +0.6% | |
| Q1 FY2010 | 1.10 | 1.18 | +7.27% | -1.67% | 5.11B | 5.49B | +7.27% | +8.69% | +0.1% | |
| Q4 FY2009 | 0.92 | 0.91 | -1.09% | -14.95% | 6.00B | 5.93B | -1.09% | +13.89% | -1.8% | |
| Q3 FY2009 | 1.02 | 1.20 | +17.65% | +15.38% | 4.73B | 5.56B | +17.65% | +6.77% | -4.5% | |
| Q2 FY2009 | 1.02 | 1.12 | +9.80% | +13.13% | 4.82B | 5.29B | +9.80% | +2.76% | -1.9% | |
| Q1 FY2009 | 0.99 | 1.20 | +21.21% | +30.43% | 4.16B | 5.05B | +21.21% | +4.98% | -2.3% | |
| Q4 FY2008 | 1.05 | 1.07 | +1.90% | +18.89% | 5.11B | 5.21B | +2.02% | +0.40% | -2.9% | |
| Q3 FY2008 | 1.02 | 1.04 | +1.96% | +14.29% | 5.11B | 5.21B | +1.96% | +13.58% | +4.3% | |
| Q2 FY2008 | 1.00 | 0.99 | -1.00% | +10.00% | 5.20B | 5.15B | -1.00% | +11.22% | +0.8% | |
| Q1 FY2008 | 0.96 | 0.92 | -4.17% | +9.52% | 5.02B | 4.81B | -4.17% | +13.76% | -4.8% | |
| Q4 FY2007 | 0.89 | 0.90 | +1.12% | +5.88% | 5.13B | 5.19B | +1.12% | +22.24% | +1.8% | |
| Q3 FY2007 | 0.87 | 0.91 | +4.60% | +13.75% | 4.39B | 4.59B | +4.60% | +18.70% | -0.5% | |
| Q2 FY2007 | 0.82 | 0.90 | +9.76% | +18.42% | 4.22B | 4.63B | +9.76% | +19.76% | 0.0% | |
| Q1 FY2007 | 0.79 | 0.84 | +6.33% | +9.09% | 3.97B | 4.23B | +6.33% | +13.77% | +2.7% | |
| Q4 FY2006 | 0.82 | 0.85 | +3.66% | +6.25% | 4.10B | 4.25B | +3.66% | +9.44% | +2.6% | |
| Q3 FY2006 | 0.79 | 0.80 | +1.27% | +9.59% | 3.82B | 3.86B | +1.27% | +7.30% | -1.3% | |
| Q2 FY2006 | 0.75 | 0.76 | +1.33% | +13.43% | 3.82B | 3.87B | +1.33% | +5.43% | -2.9% | |
| Q1 FY2006 | 0.75 | 0.77 | +2.67% | +13.24% | 3.62B | 3.71B | +2.67% | +6.21% | -1.9% | |
| Q4 FY2005 | 0.78 | 0.80 | +2.56% | +6.67% | 3.78B | 3.88B | +2.63% | +6.44% | -0.4% | |
| Q3 FY2005 | 0.71 | 0.73 | +2.82% | +5.80% | 3.50B | 3.60B | +2.82% | +9.78% | -0.7% | |
| Q2 FY2005 | 0.67 | 0.67 | 0.00% | -1.47% | 3.67B | 3.67B | 0.00% | +3.13% | -1.8% | |
| Q1 FY2005 | 0.66 | 0.68 | +3.03% | -2.86% | 3.39B | 3.50B | +3.03% | +3.57% | +1.6% | |
| Q4 FY2004 | 0.74 | 0.75 | +1.35% | +11.94% | 3.60B | 3.64B | +1.37% | +5.16% | +1.2% | |
| Q3 FY2004 | 0.68 | 0.69 | +1.47% | +4.55% | 3.23B | 3.28B | +1.47% | +4.49% | -4.5% | |
| Q2 FY2004 | 0.68 | 0.68 | 0.00% | +6.25% | 3.56B | 3.56B | 0.00% | +15.16% | -0.8% | |
| Q1 FY2004 | 0.66 | 0.70 | +6.06% | +14.75% | 3.18B | 3.38B | +6.06% | +16.87% | +1.3% | |
| Q4 FY2003 | 0.67 | 0.67 | 0.00% | -1.47% | 3.47B | 3.47B | 0.00% | +17.25% | +2.2% | |
| Q3 FY2003 | 0.66 | 0.66 | 0.00% | -2.94% | 3.14B | 3.14B | 0.00% | +12.70% | -2.8% | |
| Q2 FY2003 | 0.60 | 0.64 | +6.67% | +4.92% | 2.90B | 3.09B | +6.67% | +11.28% | +1.1% | |
| Q1 FY2003 | 0.58 | 0.61 | +5.17% | +5.17% | 2.75B | 2.89B | +5.17% | +12.82% | +3.1% | |
| Q4 FY2002 | 0.68 | 0.68 | 0.00% | +13.33% | 2.96B | 2.96B | 0.00% | +4.48% | -2.2% | |
| Q3 FY2002 | 0.68 | 0.68 | 0.00% | +3.03% | 2.79B | 2.79B | 0.00% | -3.09% | -7.8% | |
| Q2 FY2002 | 0.61 | 0.61 | 0.00% | -19.74% | 2.78B | 2.78B | 0.00% | -8.51% | -4.6% | |
| Q1 FY2002 | 0.58 | 0.58 | 0.00% | -21.62% | 2.56B | 2.56B | 0.00% | -8.72% | +2.4% | |
| Q4 FY2001 | 0.60 | 0.60 | 0.00% | -14.29% | 2.83B | 2.83B | 0.00% | -5.00% | -2.2% | |
| Q3 FY2001 | 0.66 | 0.66 | 0.00% | -7.04% | 2.87B | 2.87B | 0.00% | +2.22% | +1.5% | |
| Q2 FY2001 | 0.74 | 0.76 | +2.70% | +24.59% | 2.95B | 3.03B | +2.70% | +15.72% | +0.9% | |
| Q1 FY2001 | 0.73 | 0.74 | +1.37% | +17.46% | 2.77B | 2.81B | +1.37% | +14.47% | +2.0% | |
| Q4 FY2000 | 0.70 | 0.70 | 0.00% | +14.75% | 2.98B | 2.98B | 0.00% | +5.57% | +0.4% | |
| Q3 FY2000 | 0.71 | 0.71 | 0.00% | +14.52% | 2.81B | 2.81B | 0.00% | +8.77% | -0.8% | |
| Q2 FY2000 | 0.60 | 0.61 | +1.67% | +17.31% | 2.58B | 2.62B | +1.67% | +11.95% | -4.5% | |
| Q1 FY2000 | 0.61 | 0.63 | +3.28% | +18.87% | 2.37B | 2.45B | +3.28% | +8.67% | +3.8% | |
| Q4 FY1999 | 0.61 | 0.61 | 0.00% | +22.00% | 2.82B | 2.82B | 0.00% | +37.33% | +2.4% | |
| Q3 FY1999 | 0.62 | 0.62 | 0.00% | +16.98% | 2.59B | 2.59B | 0.00% | +9.57% | -6.1% | |
| Q2 FY1999 | 0.51 | 0.52 | +1.96% | +15.56% | 2.30B | 2.34B | +1.96% | +8.66% | -1.1% | |
| Q1 FY1999 | 0.53 | 0.53 | 0.00% | +12.77% | 2.26B | 2.26B | 0.00% | +8.08% | -11.5% | |
| Q4 FY1998 | 0.51 | 0.50 | -1.96% | +21.95% | 2.09B | 2.05B | -1.92% | -14.98% | +1.7% | |
| Q3 FY1998 | 0.51 | 0.53 | +3.92% | +29.27% | 2.27B | 2.36B | +3.92% | +9.23% | +3.5% | |
| Q2 FY1998 | 0.43 | 0.45 | +4.65% | +18.42% | 2.06B | 2.16B | +4.65% | +8.36% | +0.5% | |
| Q1 FY1998 | 0.46 | 0.47 | +2.17% | +14.63% | 2.04B | 2.09B | +2.17% | +6.86% | +5.6% | |
| Q4 FY1997 | 0.42 | 0.41 | -2.38% | +20.59% | 2.47B | 2.42B | -2.33% | +17.21% | -0.3% | |
| Q3 FY1997 | 0.40 | 0.41 | +2.50% | +7.89% | 2.11B | 2.16B | +2.50% | +19.75% | +3.0% | |
| Q2 FY1997 | 0.38 | 0.38 | 0.00% | +18.75% | 1.99B | 1.99B | 0.00% | +17.10% | +2.0% | |
| Q1 FY1997 | 0.40 | 0.41 | +2.50% | +13.89% | 1.91B | 1.95B | +2.50% | +9.52% | +0.1% | |
| Q4 FY1996 | 0.34 | 0.34 | 0.00% | +21.43% | 2.06B | 2.06B | 0.00% | +14.52% | -2.7% | |
| Q3 FY1996 | 0.32 | 0.38 | +18.75% | +40.74% | — | 1.80B | — | +10.54% | +0.7% | |
| Q2 FY1996 | 0.32 | 0.32 | 0.00% | +18.52% | — | 1.70B | — | +5.17% | -4.2% | |
| Q1 FY1996 | 0.36 | 0.36 | 0.00% | +9.09% | — | 1.78B | — | +3.84% | -2.0% | |
| Q4 FY1995 | 0.28 | 0.28 | 0.00% | +21.74% | — | 1.80B | — | +211.01% | +4.2% | |
| Q3 FY1995 | 0.27 | 0.27 | 0.00% | -12.90% | — | 1.63B | — | -10.21% | -0.4% | |
| Q2 FY1995 | 0.27 | 0.27 | 0.00% | -12.90% | — | 1.61B | — | -3.80% | +0.8% | |
| Q1 FY1995 | 0.32 | 0.33 | +3.13% | +3.13% | — | 1.72B | — | +4.91% | 0.0% | |
| Q4 FY1994 | 0.27 | 0.23 | -14.81% | -17.86% | — | 578.70M | — | -67.86% | -1.0% | |
| Q3 FY1994 | 0.29 | 0.31 | +6.90% | +24.00% | — | 1.82B | — | +18.74% | +0.4% | |
| Q2 FY1994 | 0.30 | 0.31 | +3.33% | +3.33% | — | 1.68B | — | +7.53% | -0.2% | |
| Q1 FY1994 | 0.31 | 0.32 | +3.23% | 0.00% | — | 1.64B | — | +4.94% | +2.6% | |
| Q4 FY1993 | 0.29 | 0.28 | -3.45% | +4.79% | — | 1.80B | — | +8.78% | -1.7% | |
| Q3 FY1993 | 0.24 | 0.25 | +4.17% | — | — | 1.53B | — | — | -2.8% | |
| Q2 FY1993 | 0.30 | 0.30 | 0.00% | +3.45% | — | 1.56B | — | +5.59% | +1.0% | |
| Q1 FY1993 | 0.31 | 0.32 | +3.23% | — | — | 1.56B | — | — | +3.3% | |
| Q4 FY1992 | 0.29 | 0.29 | 0.00% | +8.53% | — | 1.48B | — | -6.11% | +1.5% | |
| Q4 FY1992 | — | 0.27 | — | 0.00% | — | 1.66B | — | +5.27% | -1.6% | |
| Q2 FY1992 | — | 0.29 | — | +7.41% | — | 1.48B | — | +7.41% | -1.0% | |
| Q4 FY1991 | — | 0.38 | — | +68.74% | — | 1.56B | — | +7.85% | +1.6% | |
| Q4 FY1991 | — | 0.27 | — | +18.65% | — | 1.57B | — | +8.92% | -1.6% | |
| Q3 FY1991 | — | 0.26 | — | +13.04% | — | 1.34B | — | +4.64% | +0.7% | |
| Q2 FY1991 | — | 0.27 | — | +12.50% | — | 1.38B | — | +12.31% | +2.8% | |
| Q4 FY1990 | — | 0.34 | — | +72.94% | — | 1.44B | — | +83.10% | +1.3% | |
| Q4 FY1990 | — | 0.23 | — | +14.55% | — | 1.44B | — | +84.16% | +1.7% | |
| Q3 FY1990 | — | 0.23 | — | +21.05% | — | 1.28B | — | +22.65% | +4.5% | |
| Q2 FY1990 | — | 0.24 | — | +26.32% | — | 1.23B | — | +9.26% | +0.6% | |
| Q4 FY1989 | — | 0.29 | — | +84.48% | — | 1.24B | — | +19.03% | +0.2% | |
| Q4 FY1989 | — | 0.20 | — | +25.06% | — | 784.00M | — | -24.78% | +0.4% | |
| Q3 FY1989 | — | 0.19 | — | +21.79% | — | 1.05B | — | +11.11% | -1.2% | |
| Q2 FY1989 | — | 0.19 | — | +16.14% | — | 1.12B | — | +10.53% | -0.2% | |
| Q4 FY1988 | — | 0.26 | — | — | — | 1.23B | — | +100.98% | +0.7% | |
| Q4 FY1988 | — | 0.16 | — | — | — | 1.04B | — | +71.01% | +0.1% | |
| Q3 FY1988 | — | 0.16 | — | +15.99% | — | 940.60M | — | -1.79% | -1.3% | |
| Q2 FY1988 | — | 0.16 | — | +21.10% | — | 1.01B | — | -0.28% | +2.4% | |
| Q4 FY1987 | — | 0.21 | — | +84.15% | — | 1.07B | — | +10.59% | -0.6% | |
| Q4 FY1987 | — | -0.08 | — | -173.86% | — | 609.50M | — | -37.13% | -0.5% | |
| Q3 FY1987 | — | 0.13 | — | +10.70% | — | 957.70M | — | +8.41% | -0.5% | |
| Q2 FY1987 | — | 0.14 | — | +19.98% | — | 1.02B | — | +15.73% | -1.5% | |
| Q4 FY1986 | — | 0.18 | — | +64.29% | — | 1.06B | — | +29.62% | -1.0% | |
| Q4 FY1986 | — | 0.11 | — | +1.16% | — | 969.40M | — | +18.65% | -0.9% | |
| Q3 FY1986 | — | 0.12 | — | +11.26% | — | 883.40M | — | +12.12% | -0.2% | |
| Q2 FY1986 | — | 0.11 | — | — | — | 879.30M | — | — | +1.6% | |
| Q4 FY1985 | — | 0.15 | — | — | — | 988.30M | — | — | -1.4% | |
| Q4 FY1985 | — | 0.11 | — | — | — | 817.00M | — | — | +0.4% | |
| Q3 FY1985 | — | 0.11 | — | — | — | 787.90M | — | — | +0.4% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 57.23 | — | — | +13.90% | 118.73B | — | — | +11.21% |
| FY2027 | 50.25 | — | — | +42.10% | 106.76B | — | — | +17.12% |
| FY2026 | 35.36 | — | — | +46.05% | 91.16B | — | — | +39.86% |
| FY2025 | 23.59 | 24.21 | +2.63% | +86.23% | 63.86B | 65.18B | +2.06% | +44.70% |
| FY2024 | 12.83 | 13.00 | +1.30% | +105.70% | 45.10B | 45.04B | -0.13% | +32.00% |
| FY2023 | 6.23 | 6.32 | +1.48% | -20.40% | 33.65B | 34.12B | +1.40% | +19.56% |
| FY2022 | 7.64 | 7.94 | +3.98% | -2.82% | 28.59B | 28.54B | -0.17% | +0.79% |
The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.
From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.
The outlook will show how much growth Lilly expects as its obesity and diabetes medicines reach more patients.
On average, analysts' EPS estimate was 18.8% off the result, either way, and their revenue estimate 7.1%, over the last 12 quarters.
See also:Forecast,EPS,Income statement
Source: Financial Modeling Prep
We value your privacy
We use cookies to enhance your experience and analyze site traffic. By continuing, you agree to our use of cookies. Privacy Policy